β-hydroxybutyrate induces acute pulmonary endothelial dysfunction in rabbits

Experimental Lung Research

Volumn 30, Issue 3, 2004, Pages 193-206

  McCloud, Laryssa L ^a   Parkerson, James B ^a   Freant, Lawrence ^a   Hoffman, William H ^a   Catravas, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Angiotensin converting enzyme activity; Endothelial dysfunction; Ketone body; Pulmonary

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; KETONE BODY;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; LUNG ALVEOLUS; LUNG CAPILLARY; LUNG ENDOTHELIUM; LUNG HEMORRHAGE; LUNG INSUFFICIENCY; LUNG PERFUSION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

3-HYDROXYBUTYRIC ACID; ACUTE DISEASE; ANIMALS; CAPILLARY PERMEABILITY; DIABETIC KETOACIDOSIS; ENDOTHELIUM, VASCULAR; KETONE BODIES; LUNG; LUNG DISEASES; MALE; PEPTIDYL-DIPEPTIDASE A; PULMONARY CIRCULATION; RABBITS;

EID: 1642488968     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140490276311     Document Type: Article

References (55)

1. Johnson DD, Palumbo PJ, Chu C: Diabetic ketoacidosis in a community-based population. Mayo Clin Proc. 1980;55:83-88.
2. Faich GA, Fishbein HA, Elllis SE: The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol. 1983;117:551-558.
3. Hoffman WH, Locksmith JP, Burton EM, Shaver AL, Deane DA, Beaudreau M, Bassali RW: Interstitial pulmonary edema in children and adolescents with diabetic ketoacidosis. J Diabetes Complications. 1998;12:314-320.
4. Gomez Diaz RA, Rivera Moscoso R, Ramos Rodriguez R, Reza Albarran A, Gomez-Perez FJ, Rull J: Diabetic ketoacidosis in adults: clinical and laboratory features. Arch Med Res. 1996;27:177-181.
5. Orfanos SE, Catravas JD: Metabolic functions of the pulmonary endothelium. In: Yacoub M, Pepper J, eds. Annual Review of Cardiac Surgery. 6th ed. London, UK: Current Science; 1993:52-59.
6. Orfanos SE, Langleben D, KhouryJ, Schlesinger RD, Dragatakis L, Roussos C, Ryan JW, Catravas JD: Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans. Circulation. 1999;99:1593-1599.
7. Orfanos SE, Chen XL, Ryan JW, Chung AYK, Burch SE, Catravas JD: Assay of pulmonary microvascular endothelial angiotensin-converting enzyme in vivo: comparison of three methods. Toxicol Appl Pharmacol. 1994;124:99-111.
8. Ryan JW: Assay of pulmonary endothelial surface enzymes in vivo. In: Ryan US, ed. Pulmonary Endothelium in Health and Disease. New York, NY: Marcel Dekker; 1987:161-188.
9. Ryan JW, Catravas JD: Angiotensin converting enzyme as an indicator of pulmonary microvascular function. In: Hollinger MA, ed. Focus on Pulmonary Pharmacology and Toxicology. Boca Raton, FL: CRC Press; 1991:183-210.
10. Catravas JD, Orfanos SE: Pathologic functions of endothelial angiotensin-converting enzyme. In: Born GVR, Schwartz CJ, eds. Vascular Endothelium: Physiology, Pathology, and Therapeutic Options. Stuttgart, Germany: Schattauer; 1997:193-204.
11. Dobuler KJ, Catravas JD, Gillis CN: Early detection of oxygen-induced lung injury in conscious rabbits. Am Rev Respir Dis. 1982;126:534-539.
12. McCormick JR, Chrzyanowski R, Andreani J, Catravas JD: Early pulmonary endothelial dysfunction after phorbol ester in conscious rabbits. J Appl Physiol. 1987;63:1972-1978.
13. Orfanos S, Armaganidis A, Glynos C, Psevdo E, Kaltsas P, Sarafidou P, Catravas J, Dafhi UG, Langleben D, Roussos C: Pulmonary capillary endothelium-bound angiotensin converting enzyme activity in acute lung injury. Circulation. 2000;102:2011-2018.
14. McCloud L, Parkerson JB, Zou L, Catravas JD: Recovery from reduced pulmonary endothelium-bound angiotensin converting enzyme activity in diabetic rabbits. FASEB J. 2001;15:A331.
15. El Kashef HA, Catravas JD: Prostanoid medication of pulmonary vascular response to acetylcholine in rabbits. Am J Physiol. 1986;251:H808-H814.
16. Catravas JD, White RE: Kinetics of pulmonary angiotensin-converting enzyme and 5′-nucleotidase activities in vivo. J Appl Physiol. 1984;57:1173-1181.
17. Dupuis J, Goresky CA, Ryan JW, et al: Pulmonary angiotensin-converting enzyme substrate hydrolysis during exercise. J Appl Physiol. 1992;72:1868-1886.
18. Toivonen HJ, Catravas JD: Effects of blood flow on lung ACE kinetics: evidence for microvascular recruitment. J Appl Physiol. 1991;71:2244-2254.
19. Mitchell GA, Kassovska-Bratinova S, Boukaftane Y, Robert MF, Wang SP, Ashmarina L, Lambert M, Lapierre P, Potier E: Medical aspects of ketone body metabolism. Clin Invest Med. 1995;18:193-216.
20. Kitabichi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM: Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001;24:131-153.
21. Young MC: Simultaneous acute cerebral and pulmonary edema complicating diabetic ketoacidosis. Diabetes Care. 1995;18:1288-1290.
22. Sprung CL, Rackow EC, Fein AF: Pulmonary edema: a complication of diabetic ketoacidosis. Chest. 1980;77:687-688.
23. Brun-Buisson CJL, Bonnet F, Bergeret S, Lemaire F, Rapin M: Recurrent high permeability edema associated with diabetic ketoacidosis. Crit Care Med. 1985;13:55-56.
24. Powner D, Snyder JV, Grenik A: Altered pulmonary capillary permeability complicating recovery from diabetic ketoacidosis. Chest. 1975;68:253-256.
25. Carroll P and Matz R: Adult respiratory distress syndrome complicating severely uncontrolled diabetes mellitus: report of nine cases and a review of the literature. Diabetes Care. 1982;5:574-580.
26. Breidbart S, Singer L, St Louis Y, Saenger P: Adult respiratory distress syndrome in an adolescent with diabetic ketoacidosis. J Pediatr. 1987;111:736-738.
27. Angus DC, Musthafa AA, Clermont G, Griffin MF, Linde-Zwirble WT, Dremsizov TT, Pinsky MR: Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163:1389-1394.
28. Engelgau MM, Geiss LS: The burden of diabetes mellitus. In: Leahy JL, Clark NG, and Cefalu, WT, eds. Medical Management of Diabetes Mellitus. New York: Marcel Dekker; 2000:1-17.
29. McMillan DE: Development of vascular complications in diabetes. Vasc Med. 1997;2:132-142.
30. Sandler M: Is the lung a 'target organ' in diabetes mellitus? Arch Intern Med. 1990;150:1385-1388.
31. Kida K, Utsuyama M, Takizawa T, Thurlbeck WM:. Changes in lung morphologic features and elasticity caused by streptozbtocin-induced diabetes in rats. Am Rev Respir Dis. 1983;128:125-131.
32. Plopper CJ, Morishiga WK: Alterations in granular (type II) pneumocyte ultrastructure by streptozotocin-induced diabetes in the rat. Lab. Invest. 1978;38:143-148.
33. Vracko R: A comparison of the microvascular lesions in diabetes mellitus with those in normal aging. J Am Geriatr Soc. 1982;30:201-205.
34. Primhak RA, Whincup G, Tsanakas JN, Milner RD: Reduced vital capacity in insulin-dependent diabetes. Diabetes. 1987;36:324-326.
35. Bell D, Collier A, nicoll JJ, Jackson M, Millar AM, Clarke BF, Muir AL: Are reduced lung volumes in IDDM due to defect in connective tissue? Diabetes. 1988;37:829-831.
36. Schernthaner G, Haber P, Kummer F, Ludwig H: Lung elasticity in juvenile onset diabetes mellitus. Am Rev Respir Dis. 1977;116:544-546.
37. Strojek K, Ziora D, Sroczynski JW, Oklek K: Pulmonary complications of type 1 insulin dependent diabetes mellitus. Diabetologia. 1992;35:1173-1176.
38. Maccioni FJ, Colebatch HJ: Lung volume and distensibility in insulin-dependent diabetes mellitus. Am Rev Respir Dis. 1991;143:1253-1256.
39. Hoffman WH, Cheng C, Passmore GG, Carroll JE, Hess D: Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human microvascular endothelial cells. Neurosci Lett. 2002;334:71-74.
40. Clausen P, Jacobsen P, Rossing K, JensenJS, Parving HH, Feldt-Rasmussen B: Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with type I diabetes mellitus with microalbuminuria and overt nephropathy. Diabetes Med. 2000;17:644-649.
41. Elhadd TA, Kennedy G, Hill A, McLaren M, Newton RW, Greene SA, Belch JJ: Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease. Diabetes Metab Res Rev. 1999;15:405-411.
42. Schmitz O, Romer FK, Alberti KGMM, Hreidarsson AB, Orskov H: Angiotensin-converting enzyme in diabetes mellitus dependence on metabolic aberration. Diabetes Metab. 1983;9:179-182.
43. Bedrossian C, Woo J, Miller W, Cannon D: Decreased angiotensin- converting enzyme in the adult respiratory distress syndrome. Am J Clin Pathol. 1978;70:244-247.
44. McCloud LL, Parkerson JB, Zou L, Raol, Catravas JD: Reduced pulmonary endothelium-bound angiotensin converting enzyme activity in diabetic rabbits. Submitted.
45. Jain SK, Kannan K, Lim G: Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radie Biol Med. 1998;25:1083-1088.
46. Jain SK, McVie R, Jackson R, Levine SN, Lim G: Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients. Diabetes Care. 1999;22:1171-1175.
47. Jain SK, McVie R: Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes. 1999;48:1850-1855.
48. Abuja PM, Albertini R: Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta. 2001;306:1-17.
49. Hensley K, Williamson KS, Floyd RA: Measurement of 3-nitrotyrosine and 5-nitro-gamma-tocopherol by high-performance liquid chromatography with electrochemical detection. Free Radic Biol Med. 2000;28:520-528.
50. Radi R, Beckman JS, Bush KM, Freeman BA: Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 1991;288:481-487.
51. Dzau VJ: Tissue angiotensin and pathobiology of vascular disease. Hypertension. 2001;37:1047-1052.
52. Eriksson M, Saldeen T: Effects of an inhibitor of angiotensin converting enzyme (capotopril) on pulmonary and renal insufficiency due to intravascular coagulation in the rat. Int J Microcirc Clin Exp. 1989;8:245-258.
53. Dobuler KJ, Catravas JD, Gillis CN: Early detection of oxygen-induced lung injury in conscious rabbits. Am Rev Respir Dis. 1982;126:534-539.
54. McCormick JR, Chrzyanowski R, Andreani J, Catravas JD: Early pulmonary endothelial dysfunction after phorbol ester in conscious rabbits. J Appl Physiol. 1987;63:1972-1978.
55. Hilgenfeldt U, Kienapfil G, Kellerman W, Schott R, Schmidt M: Renin angiotensin system in sepsis. Clin Exp Hypertens. 1987;9:1493-1504.